PT Sinkona

PT Sinkona Indonesia Lestari is a leading Indonesian pharmaceutical company specializing in the production of Quinine and its derivatives from Cinchona bark. Established in 1986 as a joint venture between PT Kimia Farma and PT Perkebunan Nusantara VIII, the company is one of the world's largest producers of Quinine salts. Its product portfolio includes Quinine Sulfate, Quinine Hydrochloride, and Quinidine, which are used globally for treating malaria and cardiac conditions. The company operates a large-scale manufacturing facility in Subang, West Java, adhering to international quality standards such as Good Manufacturing Practice (GMP). Sinkona Indonesia Lestari serves as a critical supplier of active pharmaceutical ingredients (APIs) to the global healthcare industry.